Page last updated: 2024-10-29
whi p154 and Cancer of Lung
whi p154 has been researched along with Cancer of Lung in 2 studies
WHI P154: an anti-leukemic agent; structure in first source
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Zhang, H | 1 |
Zhang, YK | 1 |
Wang, YJ | 1 |
Kathawala, RJ | 1 |
Patel, A | 1 |
Zhu, H | 1 |
Sodani, K | 1 |
Talele, TT | 1 |
Ambudkar, SV | 1 |
Chen, ZS | 1 |
Fu, LW | 1 |
Wang, YW | 1 |
Tu, PH | 1 |
Lin, KT | 1 |
Lin, SC | 1 |
Ko, JY | 1 |
Jou, YS | 1 |
Other Studies
2 other studies available for whi p154 and Cancer of Lung
Article | Year |
---|---|
WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette | 2014 |
Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Anaplastic Lymphoma Kinase; Animals; Biomarkers | 2011 |